Met Life Investment Management, LLC Chroma Dex Corp. Transaction History
Met Life Investment Management, LLC
- $16.5 Billion
- Q2 2025
A detailed history of Met Life Investment Management, LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 30,126 shares of CDXC stock, worth $184,973. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,126
Previous 30,126
-0.0%
Holding current value
$184,973
Previous $207,000
11.11%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CDXC
# of Institutions
159Shares Held
26.8MCall Options Held
190KPut Options Held
14.1K-
Vanguard Group Inc Valley Forge, PA3.92MShares$24.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$19.1 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA1.58MShares$9.71 Million8.91% of portfolio
-
Geode Capital Management, LLC Boston, MA1.3MShares$7.95 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.28MShares$7.88 Million0.01% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $420M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...